SARS CoV- 2 vaccination induces antibodies against cardiolipin

OBJECTIVE: Cases of thrombosis have been reported after administration of SARS-CoV-2 vaccines, with controversial results relating to Oxford-AstraZeneca’s ChAdOx1-S. Despite such cases being rare, they still raised concerns for their involvement in coagulopathies. Anti-cardiolipin (aCL) IgG antibodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Krashias, George, Pafiti, Anna, Deeba, Elie, Christodoulou, Christina, Pantzaris, Marios, Lambrianides, Anastasia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449922/
https://www.ncbi.nlm.nih.gov/pubmed/36071440
http://dx.doi.org/10.1186/s13104-022-06180-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449922/
https://www.ncbi.nlm.nih.gov/pubmed/36071440
http://dx.doi.org/10.1186/s13104-022-06180-3

Ejemplares similares